ARM Foundation for Cell and Gene Medicine launched

The Alliance for Regenerative Medicine (ARM) launched an independent, non-profit foundation dedicated to researching, creating and disseminating information about gene and cell therapies.

The ARM Foundation for Cell and Gene Medicine has commissioned a study of the macroeconomic impacts of regenerative medicines, and market research on public awareness and acceptance of gene medicines, Stewart Parker, chair of the foundation’s board, told BioCentury. Parker is the former CEO of Targeted Genetics Corp., which ceased work on gene therapy following a series of restructurings in 2008 and 2009 and a 2011 merger that formed antibiotics company AmpliPhi Biosciences Corp. (NYSE:APHB)...